Lataa...
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
Long-acting injectable antipsychotics (LAIs) were developed to make treatment easier, improve adherence, and/or signal the clinician when nonadherence occurs. Second-generation antipsychotic LAIs (SGA-LAIs) combine the advantages of SGA with a long-acting formulation. The purpose of this review is t...
Tallennettuna:
| Julkaisussa: | Neuropsychiatr Dis Treat |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844443/ https://ncbi.nlm.nih.gov/pubmed/27143893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S88632 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|